Because frataxin has anti-oxidant properties, cellular defences against ROS are impaired in FRDA, and this likely further exacerbates neuronal loss (Rustin et al., 1999; Rotig et al., 2002; Schmucker and Puccio, 2010). This evidence concerns the gene FXN and Friedreich ataxia.